Northwestern Mutual Wealth Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-20
| Closed | -$61 | – | 4015 |
|
|
2024
Q4 | $61 | Sell |
20
-1,680
| -99% | -$5.12K | ﹤0.01% | 3510 |
|
|
2024
Q3 | $8.82K | Sell |
1,700
-1,602
| -49% | -$8.31K | ﹤0.01% | 2726 |
|
|
2024
Q2 | $8.49K | Buy |
+3,302
| New | +$8.49K | ﹤0.01% | 2702 |
|
|
2024
Q1 | – | Sell |
-4,400
| Closed | -$38.7K | – | 3856 |
|
|
2023
Q4 | $38.7K | Buy |
+4,400
| New | +$38.7K | ﹤0.01% | 2162 |
|
|
2023
Q3 | – | Sell |
-50
| Closed | -$1.27K | – | 3572 |
|
|
2023
Q2 | $1.27K | Buy |
50
+45
| +900% | +$1.14K | ﹤0.01% | 3055 |
|
|
2023
Q1 | $161 | Buy |
+5
| New | +$161 | ﹤0.01% | 3207 |
|
|
2021
Q1 | – | Sell |
-71
| Closed | -$2K | – | 2993 |
|
|
2020
Q4 | $2K | Buy |
+71
| New | +$2K | ﹤0.01% | 2558 |
|